TCS posted a 1.7% year-on-year drop in consolidated net profit to Rs 12,224 crore for the quarter ending March 2025, down from Rs 12,434 crore in the same period last year. The result came in slightly below analysts’ expectations of Rs 12,650 crore.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.